FDA chief apologizes for overstating convalescent plasma's effect against COVID-19

Responding to an outcry from medical experts, U.S. Food and Drug Administration Commissioner Stephen Hahn on Tuesday apologized for overstating the life-saving benefits of treating COVID-19 patients with convalescent plasma.